These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39264189)

  • 41. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Al-Baqsami ZF; Ahmad S; Khan Z
    Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
    Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
    Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study.
    Suphavilai C; Ko KKK; Lim KM; Tan MG; Boonsimma P; Chu JJK; Goh SS; Rajandran P; Lee LC; Tan KY; Shaik Ismail BB; Aung MK; Yang Y; Sim JXY; Venkatachalam I; Cherng BPZ; Spruijtenburg B; Chan KS; Oon LLE; Tan AL; Tan YE; Wijaya L; Tan BH; Ling ML; Koh TH; Meis JF; Tsui CKM; Nagarajan N
    Lancet Microbe; 2024 Sep; 5(9):100878. PubMed ID: 39008997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
    Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter Candida auris outbreak caused by azole-susceptible clade IV in Pernambuco, Brazil.
    Spruijtenburg B; Nobrega de Almeida Júnior J; Ribeiro FC; Kemmerich KK; Baeta K; Meijer EFJ; de Groot T; Meis JF; Colombo AL;
    Mycoses; 2024 Jun; 67(6):e13752. PubMed ID: 38880933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal Susceptibility Testing and Cluster Analysis of Candida auris Strains.
    Ozmerdiven GE; Irvem A; Cizmeci Z
    Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.
    Diekema DJ; Messer SA; Boyken LB; Hollis RJ; Kroeger J; Tendolkar S; Pfaller MA
    J Clin Microbiol; 2009 Oct; 47(10):3170-7. PubMed ID: 19710283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.
    Dudiuk C; Berrio I; Leonardelli F; Morales-Lopez S; Theill L; Macedo D; Yesid-Rodriguez J; Salcedo S; Marin A; Gamarra S; Garcia-Effron G
    J Antimicrob Chemother; 2019 Aug; 74(8):2295-2302. PubMed ID: 31081031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with hematological malignancies.
    Malchikova A; Klyasova G
    J Mycol Med; 2021 Sep; 31(3):101162. PubMed ID: 34147758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
    Lockhart SR; Etienne KA; Vallabhaneni S; Farooqi J; Chowdhary A; Govender NP; Colombo AL; Calvo B; Cuomo CA; Desjardins CA; Berkow EL; Castanheira M; Magobo RE; Jabeen K; Asghar RJ; Meis JF; Jackson B; Chiller T; Litvintseva AP
    Clin Infect Dis; 2017 Jan; 64(2):134-140. PubMed ID: 27988485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
    Amran F; Aziz MN; Ibrahim HM; Atiqah NH; Parameswari S; Hafiza MR; Ifwat M
    J Med Microbiol; 2011 Sep; 60(Pt 9):1312-1316. PubMed ID: 21459913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris.
    Chen J; Tian S; Han X; Chu Y; Wang Q; Zhou B; Shang H
    BMC Infect Dis; 2020 Nov; 20(1):827. PubMed ID: 33176724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.
    Autmizguine J; Tan S; Cohen-Wolkowiez M; Cotten CM; Wiederhold N; Goldberg RN; Adams-Chapman I; Stoll BJ; Smith PB; Benjamin DK;
    Pediatr Infect Dis J; 2018 Sep; 37(9):923-929. PubMed ID: 29369937
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Hager CL; Larkin EL; Long L; Zohra Abidi F; Shaw KJ; Ghannoum MA
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311065
    [No Abstract]   [Full Text] [Related]  

  • 59. Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.
    Jacobs SE; Jacobs JL; Dennis EK; Taimur S; Rana M; Patel D; Gitman M; Patel G; Schaefer S; Iyer K; Moon J; Adams V; Lerner P; Walsh TJ; Zhu Y; Anower MR; Vaidya MM; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0005322. PubMed ID: 35770999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in antifungal resistance in
    Díaz-García J; Machado M; Alcalá L; Reigadas E; Pérez-Ayala A; Gómez-García de la Pedrosa E; Gónzalez-Romo F; Cuétara MS; García-Esteban C; Quiles-Melero I; Zurita ND; Muñoz-Algarra M; Durán-Valle MT; Sánchez-García A; Muñoz P; Escribano P; Guinea J;
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0098623. PubMed ID: 38092562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.